Neuren Pharmaceuticals LimitedASX: NEU

Compelling results for 2591 dose ranging study in PMS model

Mar 6, 2020 at 4:13 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment